Are steroids removed by dialysis, and is dose adjustment required for patients on dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Steroids Are NOT Significantly Removed by Dialysis

Corticosteroids do not require dose adjustment for patients on hemodialysis because they are not significantly dialyzable. Steroids have high molecular weight, extensive protein binding, wide tissue distribution, and undergo primarily hepatic metabolism—all characteristics that prevent meaningful removal during dialysis 1, 2.

Pharmacokinetic Properties Preventing Dialysis Removal

  • High protein binding and large volume of distribution prevent corticosteroids from being effectively cleared by hemodialysis membranes 1.
  • Hepatic metabolism is the primary elimination pathway for steroids, not renal excretion, so renal replacement therapy does not significantly impact their clearance 3.
  • Methylprednisolone demonstrates a dialysance of only 18.4 ± 6.1 ml/min with a half-life of 149 ± 26 minutes during hemodialysis—this minimal clearance is clinically insignificant 1.

Dosing Recommendations for Dialysis Patients

  • No dose adjustment is necessary for prednisone, methylprednisolone, or other corticosteroids in patients with end-stage renal disease or those receiving hemodialysis 3, 2.
  • Standard dosing regimens should be maintained regardless of dialysis schedule, as the amount removed during a dialysis session is negligible 1, 2.
  • No supplemental dose is required after hemodialysis, unlike drugs that are significantly dialyzable (e.g., aminoglycosides, pyrazinamide) 3, 4.

Clinical Context and Monitoring

  • Patients on chronic steroid therapy who develop renal failure and require dialysis should continue their usual steroid regimen without modification for the dialysis procedure 5, 2.
  • The risk of steroid-related complications (infection, malnutrition, hyperglycemia) may be higher in dialysis patients, but this relates to the underlying uremic state and immunosuppression, not to altered steroid pharmacokinetics 2.
  • Adrenal insufficiency remains a concern during perioperative stress in dialysis patients on chronic steroids, requiring the same stress-dose considerations as non-dialysis patients 5.

Common Pitfall to Avoid

  • Do not reduce steroid doses or add supplemental doses based on dialysis timing—this practice is unnecessary and may lead to under-treatment of the underlying condition requiring steroid therapy 1, 2.
  • Unlike renally cleared drugs (ethambutol, pyrazinamide, aminoglycosides) that require interval extension or post-dialysis supplementation, steroids follow standard dosing regardless of renal function 3, 4.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.